Vapormed Mighty+ MEDIC Modo De Empleo página 53

4 I M P O R TA N T I N F O R M AT I O N A B O U T
When observing the Instructions for Use and with a vaporization temperature
of 210°C (410°F) the following exemplary reference values are validated for
hemp flowers with a cannabinoid content of e.g. 19% THC and 0% CBD:
Amount of
hemp flowers
(Dosing
Capsule
content)
50 mg
100 mg
150 mg
Reference values for hemp flowers with a cannabinoid content of e.g. 6% THC
and 7.5% CBD:
Amount of
hemp flowers
(Dosing
Capsule
content)
50 mg
100 mg
150 mg
In order to reach these values, inhalation must be continued until there is no
aerosol (vapor) recognizable when exhaling. The Dosing Capsule's content is
then depleted.
C A N N A B I N O I D S
Cannabinoid
content of the
hemp flower
portion
THC: 9.5 mg
THC: 19 mg
THC: 28.5 mg
Cannabinoid
Cannabinoid
content in
content of the
the aerosol
hemp flower
(vapor)
portion
THC: 3 mg
approx. 1.5 mg
CBD:
approx. 1.6 mg
approx. 3.2 mg
THC: 6 mg
approx. 3 mg
CBD:
approx. 3.7 mg
approx. 7.5 mg
THC: 9 mg
approx. 4.5 mg
CBD:
approx. 5.5 mg
approx. 11 mg
53
Cannabinoid
content in
the aerosol
(vapor)
approx. 5 mg
approx. 9.5 mg
approx. 14 mg
Cannabinoid
content in blood
stream (systemic
bioavailability) after
inhalation
approx. 3 mg
approx. 6 mg
approx. 9.5 mg
Cannabinoid
content in blood
stream (systemic
bioavailability) after
inhalation
approx. 1 mg
approx. 1.1 mg
approx. 2 mg
approx. 2.3 mg
approx. 3 mg
approx. 3.5 mg